Adamas Pharmaceuticals
Create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD545m (Public information from Oct 2021)
Share price
$8.22 ADMS
Emeryville California (HQ)
Authorizing premium user...